The Biotech Startups Podcast podcast

If It's Getting More Complex, You're Going the Wrong Way | Scott Chetham (4/4)

0:00
40:45
Rewind 15 seconds
Fast Forward 15 seconds
Scott Chetham explains why he left Google and Verily to tackle the unglamorous planning work that slows clinical development. He recounts sketching the company in Costa Rica, raising a pre-napkin-stage round with Polaris, finding an early customer, and adapting when COVID-19 disrupted pharma economics.

More episodes from "The Biotech Startups Podcast"